Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing.
Truong DD, Lamhamedi-Cherradi SE, Porter RW, Krishnan S, Swaminathan J, Gibson A, Lazar AJ, Livingston JA, Gopalakrishnan V, Gordon N, Daw NC, Navin NE, Gorlick R, Ludwig JA. Truong DD, et al. Among authors: ludwig ja. BMC Cancer. 2023 May 31;23(1):488. doi: 10.1186/s12885-023-10977-1. BMC Cancer. 2023. PMID: 37254069 Free PMC article.
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).
Carmagnani Pestana R, Moyers JT, Roszik J, Sen S, Hong DS, Naing A, Herzog CE, Fu S, Piha-Paul SA, Rodon J, Yap TA, Karp DD, Tsimberidou AM, Pant S, Zarzour MA, Ratan R, Ravi V, Benjamin RS, Lazar AJ, Wang WL, Daw N, Gill JB, Harrison DJ, Lewis VO, Roland CL, Patel SR, Livingston JA, Somaiah N, Ludwig JA, Conley AP, Hamerschlak N, Gorlick R, Meric-Bernstam F, Subbiah V. Carmagnani Pestana R, et al. Among authors: ludwig ja. Clin Cancer Res. 2023 May 1;29(9):1708-1718. doi: 10.1158/1078-0432.CCR-22-3629. Clin Cancer Res. 2023. PMID: 37058010 Free PMC article.
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma.
Lamhamedi-Cherradi SE, Maitituoheti M, Menegaz BA, Krishnan S, Vetter AM, Camacho P, Wu CC, Beird HC, Porter RW, Ingram DR, Ramamoorthy V, Mohiuddin S, McCall D, Truong DD, Cuglievan B, Futreal PA, Velasco AR, Anvar NE, Utama B, Titus M, Lazar AJ, Wang WL, Rodriguez-Aguayo C, Ratan R, Livingston JA, Rai K, MacLeod AR, Daw NC, Hayes-Jordan A, Ludwig JA. Lamhamedi-Cherradi SE, et al. Among authors: ludwig ja. Nat Commun. 2022 Jun 1;13(1):3057. doi: 10.1038/s41467-022-30710-z. Nat Commun. 2022. PMID: 35650195 Free PMC article.
Understanding sarcoma drug resistance one cell at a time.
Cherradi-Lamhamedi SE, Truong D, Ludwig JA. Cherradi-Lamhamedi SE, et al. Among authors: ludwig ja. Cancer Drug Resist. 2022 Jan 19;5(1):90-92. doi: 10.20517/cdr.2021.87. eCollection 2022. Cancer Drug Resist. 2022. PMID: 35582528 Free PMC article. No abstract available.
Commentary: A Special Edition in bone sarcoma.
Ludwig JA, Van Tine B. Ludwig JA, et al. J Bone Oncol. 2022 Apr 20;34:100426. doi: 10.1016/j.jbo.2022.100426. eCollection 2022 Jun. J Bone Oncol. 2022. PMID: 35517059 Free PMC article. No abstract available.
65 results